Citas bibligráficas
Condemarín, K., (2022). Suplemento con vitamina K para el control metabólico en pacientes con Diabetes Melllitus Tipo 2. Revisión sistemática [Tesis, Universidad Privada Antenor Orrego. Facultad de Medicina Humana]. https://hdl.handle.net/20.500.12759/9097
Condemarín, K., Suplemento con vitamina K para el control metabólico en pacientes con Diabetes Melllitus Tipo 2. Revisión sistemática [Tesis]. PE: Universidad Privada Antenor Orrego. Facultad de Medicina Humana; 2022. https://hdl.handle.net/20.500.12759/9097
@misc{renati/380301,
title = "Suplemento con vitamina K para el control metabólico en pacientes con Diabetes Melllitus Tipo 2. Revisión sistemática",
author = "Condemarín Torres, Kathleen Alexandra",
publisher = "Universidad Privada Antenor Orrego. Facultad de Medicina Humana",
year = "2022"
}
To determine the effect of vitamin K supplementation on metabolic control in patients with type 2 diabetes mellitus. Material and methods: Systematic review of randomised controlled trials (RCTs) in five databases. Two authors independently selected studies and extracted information. Risk of bias was performed using the Cochrane collaboration tool. Primary outcomes were need for fasting blood sugar (FBS), total choresterol, high-density lipoprotein (HDL) and low-density lipoprotein (LDL). We used mean difference (MD) to assess the effect on continuous outcomes. We used random-effect model. Results: We included two RCTs (n=100). Vitamin K lowers FBG but it wasn't significant (MD -14.58; IC95% -35.95 to 6.78; p=0.18) in comparison with placebo group. Vitamin K supplement has no significant effect in cholesterol total (MD - 1.22; IC95% -21.02 to 18.57; p=0.90), HDL (MD -3.61; IC95% -18.44 to 11.22; p=0.63) and LDL (MD -0.69; IC95% -5.81 to 4.43; p=0.79) levels compared with placebo group. Conclusions: Vitamin K supplement has no effect on metabolic control on patients diagnosed with type 2 diabetes.
Este ítem está sujeto a una licencia Creative Commons Licencia Creative Commons